COWAN CHAD (Chief Scientific Officer) received a stock award from CENTURY THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2026ACC: 0002039294-26-000004
Officer· Chief Scientific Officer
Since Mar 2026
+400K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
400K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+135K
Price / share
—
Trade value
—
% of position
12.9%
2/2/2026
1.04M→1.18M
Total
Net shares
+135K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +135K | — | — | 12.9% | 1.04M | 1.18M |
| Total | +135K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
265K shares
Shares
+265K
Strike price
1.84
Held after
265K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock265K shares | 2/2/2026 | A · Award | +265K | 1.84 | — | 265K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10.70K
Total
10.70K indirect10.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.70K | Indirect |
| Total | 10.70K | 10.70K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported